This list is an analysis based on recent market events. It's not an investment recommendation.
About
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Show more...
CEO
Mr. J. Christopher Barry
Employees
2700
Country
United States
ISIN
US6707041058
WKN
000A0CAYR
Listings
0 Comments
Share your thoughts
FAQ
What is Nuvasive stock price today?▼
The current price of NK8.F is €36.8 EUR — it has increased by +0% in the past 24 hours. Watch Nuvasive stock price performance more closely on the chart.
What is Nuvasive stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nuvasive stocks are traded under the ticker NK8.F.
What is Nuvasive market cap?▼
Today Nuvasive has the market capitalization of 1.92B
What is Nuvasive revenue for the last year?▼
Nuvasive revenue for the last year amounts to 1.14B EUR.
What is Nuvasive net income for the last year?▼
NK8.F net income for the last year is 36.91M EUR.
How many employees does Nuvasive have?▼
As of April 29, 2026, the company has 2,700 employees.
In which sector is Nuvasive located?▼
Nuvasive operates in the Health & Wellness sector.
When did Nuvasive complete a stock split?▼
Nuvasive has not had any recent stock splits.
Where is Nuvasive headquartered?▼
Nuvasive is headquartered in San Diego, United States.